Most common sits at the center of this dementia and brain health question.
The most common medication side effects in elderly patients include falls and fractures, cognitive impairment and delirium, gastrointestinal bleeding, and dangerously low blood sugar. These are not rare complications — roughly 35% of ambulatory older adults experience an adverse drug reaction each year, and 29% of those reactions are serious enough to require hospitalization. A person in their mid-70s taking warfarin for atrial fibrillation, a common scenario, may be prescribed an antibiotic for a urinary tract infection without anyone flagging that the combination significantly raises the risk of internal bleeding. That kind of gap in oversight is a central driver of preventable harm.
The scale of the problem is larger than most families realize. Adults 65 and older make up approximately 14% of the U.S. population but account for 56% of hospitalizations tied to adverse drug events. Adverse reactions are responsible for around 10% of emergency room visits and 25% of hospital admissions in this age group. This article covers why older adults are physiologically more vulnerable to drug side effects, which drug classes carry the highest risks, and what practical steps patients, caregivers, and families can take to reduce exposure to preventable harm — including what to ask at the next doctor’s appointment.
Table of Contents
- Why Are Medication Side Effects So Common in Elderly Patients?
- How Do Falls and Fractures Become a Medication Side Effect?
- The Connection Between Common Medications and Cognitive Decline in Older Adults
- Which Medications Are Most Dangerous for Elderly Patients? Understanding the Beers Criteria
- Insulin, Blood Sugar Medications, and the Risk of Serious Hypoglycemia
- Dementia Patients Face Disproportionate Exposure to High-Risk Prescriptions
- Where Medication Safety for Older Adults Is Headed
- Conclusion
- Frequently Asked Questions
Why Are Medication Side Effects So Common in Elderly Patients?
Aging changes nearly every system the body uses to process drugs. The kidneys filter medications more slowly, the liver metabolizes them less efficiently, and body composition shifts — less muscle, more fat — which affects how drugs are distributed and stored. A dose that was appropriate at 55 may be excessive at 75 simply because the body handles it differently. These physiological changes are predictable, but they are not always accounted for when prescriptions are written or renewed. Polypharmacy compounds the problem considerably. Nearly 90% of older adults take at least one prescription drug regularly, and 36% take five or more.
When five or more medications are in play simultaneously, the number of potential drug-drug interactions increases exponentially, not linearly. Each new prescription added to a regimen raises the chance that something will interact with, amplify, or counteract something else. Research published in StatPearls and indexed by the National Institutes of Health has established that polypharmacy is independently associated with falls, frailty, disability, and mortality — not just as a correlate, but as a contributing cause. Between one in four and one in seven older patients has received at least one medication considered potentially inappropriate for their age group, according to a study published in JAMA Network Open. This is not a fringe problem affecting the very frail or the very old. It shows up in routine outpatient care for relatively healthy older adults. The gap between what evidence recommends and what gets prescribed is wide, and it has real consequences.
How Do Falls and Fractures Become a Medication Side Effect?
Falls are the leading cause of injury-related death among older adults in the United States, and a meaningful portion of those falls are medication-related. Benzodiazepines — drugs like lorazepam, diazepam, and clonazepam, prescribed for anxiety, sleep, or muscle spasms — are among the most well-documented culprits. They cause sedation, impair balance and coordination, and slow reaction time. Nonbenzodiazepine sleep aids, often called Z-drugs, including zolpidem (Ambien) and eszopiclone (Lunesta), carry similar risks despite being marketed as safer alternatives. Both categories appear prominently in the Beers Criteria, a widely used clinical guideline identifying medications that pose elevated risks for older adults. The mechanism is straightforward.
A drug that causes drowsiness or impairs motor control in a younger person might produce mild inconvenience. In a 78-year-old with reduced bone density and slower reflexes, the same drug can trigger a fall that results in a hip fracture — a serious injury associated with significant mortality and loss of independence in the months that follow. CNS-active drugs as a broader category, including certain antidepressants, antipsychotics, and antihistamines with sedating properties, raise fall and fracture risk through similar pathways, according to the MSD Manual’s guidance on drug categories of concern in older adults. However, this does not mean that patients with genuine anxiety or sleep disorders should simply stop taking prescribed medications. Abrupt discontinuation of benzodiazepines can trigger serious withdrawal effects. The relevant question is whether the prescription is still appropriate, whether the dose can be reduced, and whether non-pharmacological alternatives — cognitive behavioral therapy for insomnia, for example — have been explored. The risk of staying on a medication and the risk of stopping it are both real and require clinical judgment.
The Connection Between Common Medications and Cognitive Decline in Older Adults
Drug-induced cognitive impairment is a recognized medical phenomenon, but according to a 2024 review published in Springer’s Drug Safety journal, it remains “well-established yet under-recognised” in clinical practice. What that means in practice is that a patient who develops memory problems, confusion, or personality changes may be told these symptoms are signs of dementia when they are in fact side effects of a medication — or are being made worse by one. Anticholinergic drugs are particularly concerning. This class includes certain bladder medications like oxybutynin, older antihistamines like diphenhydramine (the active ingredient in Benadryl), and some antidepressants. They work by blocking acetylcholine, a neurotransmitter involved in memory and cognition.
In older adults, who already have reduced cholinergic activity in the brain, this blockade can cause confusion, memory impairment, and in acute cases, full delirium. The effect is sometimes reversible when the drug is stopped, but cumulative anticholinergic exposure over years has been studied as a potential contributor to long-term cognitive decline. Opioids and benzodiazepines also appear on the list of top contributors to drug-induced cognitive impairment. An older adult recovering from surgery who is prescribed opioids for pain management, and who is also taking a benzodiazepine for anxiety, may experience confusion and disorientation that gets attributed to the stress of hospitalization rather than to the drug combination. In dementia care specifically, this misattribution can lead to inappropriate escalation of psychiatric medications — treating a drug side effect with another drug.
Which Medications Are Most Dangerous for Elderly Patients? Understanding the Beers Criteria
The Beers Criteria is a clinical tool originally developed by geriatrician Mark Beers in 1991 and updated regularly by the American Geriatrics Society. It identifies specific medications and drug classes that carry elevated risk for adults 65 and older due to the physiological changes of aging. It is not a list of medications that should never be used — rather, it is a framework for prompting clinicians and pharmacists to weigh risks more carefully and consider alternatives. Key drug classes on the Beers Criteria include anticholinergics (bladder drugs and sedating antihistamines), benzodiazepines and Z-drugs, NSAIDs like ibuprofen and naproxen, anticoagulants and antiplatelets, insulin and sulfonylureas, and antipsychotics. NSAIDs deserve particular attention. They are widely available over the counter and are sometimes used casually for arthritis pain or headaches. In older adults, NSAIDs can cause gastrointestinal bleeding, ulcers, or perforation, and can worsen kidney function and raise blood pressure.
The combination of an NSAID with an anticoagulant like warfarin substantially elevates bleeding risk. The tradeoff here is a real one. NSAIDs are often genuinely effective for musculoskeletal pain that acetaminophen does not adequately control. For some patients, the alternative — using opioids for chronic pain management — carries its own serious risks. Acetaminophen at appropriate doses is generally safer for older adults, but it has limitations in terms of anti-inflammatory effect. Topical NSAIDs, which have much lower systemic absorption, represent a middle option that is often underused. The point is not that one answer fits every situation, but that these tradeoffs should be made explicitly rather than by default.
Insulin, Blood Sugar Medications, and the Risk of Serious Hypoglycemia
Insulin and oral hypoglycemic drugs, particularly sulfonylureas like glipizide and glyburide, are among the drug classes most commonly associated with serious adverse events in older adults. Hypoglycemia — dangerously low blood sugar — can cause confusion, loss of consciousness, seizures, and cardiac arrhythmias. In a younger person with intact physiological responses, early symptoms of low blood sugar typically trigger a corrective response. In older adults, these warning symptoms are often blunted or absent, meaning blood sugar can drop to dangerous levels without clear warning. The clinical picture is further complicated by the fact that tight glycemic control, which reduces long-term complications of diabetes over decades, provides less benefit and more risk in older adults with limited life expectancy or multiple comorbidities.
Hemoglobin A1c targets that are appropriate for a 55-year-old may be overly aggressive for an 80-year-old who lives alone. When a person experiences a hypoglycemic episode at home without anyone nearby, the consequences can be severe and fast-moving. A warning is warranted here: the appropriate blood sugar management strategy for any individual must be worked out with their physician, taking into account their overall health status, kidney function, and living situation. The concern about hypoglycemia risk is not a reason for patients to stop insulin or diabetes medications on their own. It is a reason to have an explicit conversation about whether the current targets and drug regimen remain appropriate, and whether the monitoring plan reflects the real risks.
Dementia Patients Face Disproportionate Exposure to High-Risk Prescriptions
A study reported by ScienceDaily in January 2026 found that one in four older adults with dementia is still being prescribed medications associated with falls and hospitalization. The study tracked CNS-active medication use over a nine-year period and found that the rate of potentially inappropriate prescriptions dropped from 20% to 16% — a meaningful improvement, but one that leaves a large number of vulnerable patients still exposed. More striking, as of 2021, over two-thirds of patients receiving these prescriptions had no documented clinical indication in their records. For families navigating dementia care, this matters practically.
Behavioral symptoms of dementia — agitation, sleep disturbance, anxiety — are sometimes managed with antipsychotics, benzodiazepines, or sedating antihistamines. These drugs carry documented risks including increased stroke risk and mortality in older dementia patients. Non-pharmacological approaches, including structured routines, sensory interventions, and caregiver training, have evidence behind them. When medications are used, they should be documented with a clear rationale, reviewed regularly, and stopped if the indication no longer applies.
Where Medication Safety for Older Adults Is Headed
The recognition that standard drug dosing is often calibrated for younger adults — and that older adults are underrepresented in clinical drug trials — has been growing for decades. Regulatory and professional bodies have made incremental progress: the Beers Criteria has been updated multiple times, Medicare now includes medication therapy management programs for high-risk patients, and pharmacist-led medication reviews have expanded in some health systems. The January 2026 findings about dementia patients and inappropriate prescriptions suggest that awareness and better tools are gradually reducing exposure, though the pace is slow relative to the scale of the problem.
The most actionable development for patients and families in the near term is the growing availability of geriatric pharmacists and pharmacist-led medication reconciliation services. These reviews, in which every medication a patient takes is systematically evaluated for appropriateness, interactions, and continued indication, have been shown to reduce adverse drug events when implemented rigorously. Asking for a comprehensive medication review — particularly after a hospitalization, after a new diagnosis, or when five or more medications are in use — is one of the higher-value steps a caregiver or patient can take.
Conclusion
The most common medication side effects in elderly patients — falls, cognitive impairment, bleeding, and hypoglycemia — are largely predictable, frequently preventable, and too often treated as an inevitable consequence of aging rather than as addressable clinical problems. The data are unambiguous: older adults are hospitalized for adverse drug events at disproportionate rates, polypharmacy is a systemic driver of those events, and a meaningful fraction of the medications causing harm are ones that guidelines already flag as inappropriate for this population. The pharmacology of aging is well understood.
The gap is in applying that knowledge consistently at the point of care. For caregivers and family members of older adults, the most important step is to maintain an accurate, complete list of every medication being taken — prescription, over-the-counter, and supplement — and to request a formal medication review when anything changes or when the total count crosses five medications. For patients with dementia in particular, any new behavioral symptom or sudden change in cognition warrants asking whether a medication could be contributing before assuming the condition has progressed. The goal is not to avoid all medication — drugs save lives — but to ensure that every prescription in an older adult’s regimen still justifies its presence given the risks it carries.
Frequently Asked Questions
What is the Beers Criteria and should I ask my doctor about it?
The Beers Criteria is a list of medications considered potentially inappropriate for adults 65 and older, updated periodically by the American Geriatrics Society. It includes specific drugs and drug classes that carry elevated risks due to how older bodies process medications. If you or a family member is taking medications for sleep, anxiety, bladder control, allergies, or pain, it is reasonable to ask whether any of them appear on the Beers Criteria and whether alternatives have been considered.
Can medications cause symptoms that look like dementia?
Yes. Drug-induced cognitive impairment is a documented phenomenon. Anticholinergic drugs, benzodiazepines, and opioids are among the most common contributors. Symptoms can include memory problems, confusion, and personality changes. In some cases these symptoms are reversible when the offending medication is stopped or reduced, which is why a medication review should be part of the workup when cognitive changes appear or worsen.
How many medications are too many for an older adult?
Polypharmacy is generally defined as taking five or more medications simultaneously. Research has linked this threshold to significantly elevated risks of falls, frailty, disability, and mortality in older adults. This does not mean that five or more medications are always inappropriate — some patients genuinely need them — but it does mean the full list warrants regular review to identify anything that can be safely stopped or reduced.
Are over-the-counter medications safe for older adults?
Not automatically. Several over-the-counter drugs carry specific risks for older adults. Diphenhydramine (Benadryl and many generic sleep aids) is an anticholinergic that can impair cognition and is on the Beers Criteria. Ibuprofen and naproxen (NSAIDs) can cause gastrointestinal bleeding and kidney problems. Even medications that are appropriate for younger adults may require dose adjustments or monitoring in older patients.
What should I do if I suspect a medication is causing side effects?
Do not stop a prescription medication abruptly without medical guidance, as some drugs — particularly benzodiazepines and certain antidepressants — require a supervised taper to discontinue safely. Contact the prescribing physician or a pharmacist to report the symptoms and ask whether the medication could be a contributing cause. Bringing a complete medication list to the appointment is essential, including all over-the-counter drugs and supplements.
Are dementia patients at higher risk for medication side effects?
Yes, substantially. People with dementia are less able to report symptoms, which delays recognition of adverse reactions. They are also more neurologically vulnerable to drugs that affect the brain, including sedatives and anticholinergics. A study reported in January 2026 found that one in four older adults with dementia is still being prescribed medications linked to falls and hospitalization, often without a documented clinical reason.
You Might Also Like
- What are the most common causes of dizziness in older adults and treatments
- What are the warning signs of a urinary tract infection in elderly
- What are the common causes of leg swelling in seniors
For more, see National Institute on Aging.
